TriLink is the leading provider of messenger RNAs (mRNAs) for research and clinical applications. Our pre-designed, stocked mRNAs resemble fully processed, capped, and polyadenylated mRNAs ready for translation by the ribosome.
TriLink offers a variety of stocked reporter RNAs. These are useful for tracking transfection efficiency and duration of expression in cultured cells, or in vivo.
TriLink offers mRNAs for genome engineering, including Cas9, Cas9 Nickase, and Cre recombinase.
mRNA offers a highly efficient platform for delivering vaccine antigens, and TriLink provides mRNAs expressing the model antigen, Ova.
